Chronic hepatitis C and diabetes: More questions than answers with the new direct acting antiviral drugs?

Digestive and Liver Disease

Volumn 48, Issue 9, 2016, Pages 1101-

  Wynter, Javelle ^a   Stine, Jonathan G ^b   Shah, Neeral L ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Division of Gastroenterology and Hepatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIVIRUS AGENT; DIRECT ACTING ANTIVIRAL AGENT; HEMOGLOBIN A1C; INTERFERON; UNCLASSIFIED DRUG;

ANOREXIA; CELL FUNCTION; CHRONIC HEPATITIS C; HUMAN; INSULIN RESISTANCE; LETTER; LIVER CIRRHOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN DEPLETION; DIABETES MELLITUS; HEPACIVIRUS;

ANTIVIRAL AGENTS; DIABETES MELLITUS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS;

EID: 84975140870     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2016.05.007     Document Type: Letter

References (5)

1. [1] Greenberg, P.D., Rosman, A.S., Eldeiry, L.S., et al. Decline in haemoglobin A1c values in diabetic patients receiving interferon-alpha and ribavirin for chronic hepatitis C. Journal of Viral Hepatitis 13 (2006), 613–617.
2. [2] Kawaguchi, T., Eitaro, T., Minoru, I., et al. Insulin resistance and chronic liver disease. World Journal of Hepatology 3 (2011), 99–107.
3. [3] Mehta, S.H., Brancati, L.F.L., Sulkowski, M.S., et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Annals of Internal Medicine 133 (2000), 592–599.
4. [4] De Francheschi, L., Fattovich, G., Turrini, F., et al. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology 31 (2000), 997–1004.
5. [5] Vanni, E., Bugianesi, E., Saracco, G., Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality? Editrice Gastoenterologica Italiana, Turin, Italy. Digestive and Liver Disease 48 (2016), 105–111.